Alto Neuroscience, Inc. (ANRO) › Capital ExpendituresAlto Neuroscience, Inc. (ANRO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $470.0K2024: $2.08M2025: $24.0K$24.0K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$24.0K-98.8%2024$2.08M+341.5%2023$470.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share